AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

American Journal of Public Health, Vol. 70, Issue 5 485-491, Copyright © 1980 by American Public Health Association

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ray, W A
Right arrow Articles by Schaffner, W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ray, W A
Right arrow Articles by Schaffner, W
A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse.

W A Ray, C F Federspiel and W Schaffner

We reviewed 384,326 prescriptions for 5,902 Medicaid patients residing continuously for one year in 173 Tennessee nursing homes. Of these patients, 43 per cent received antipsychotic drugs; 9 per cent were chronic recipients (received at least 365 daily doses per year). Of the 1,580 physicians who cared for these patients, 42 per cent prescribed antipsychotic medication. Physicians with large nursing home practices (10 or more patients) prescribed 81 per cent of the total antipsychotic medication, and were usually family practitioners (78 per cent) and in rural practice (47 per cent). As nursing home practice size increased, doctors prescribed more drug per patient (p less than .001). Wide variation in antipsychotic drug use occurred among nursing homes; the chronic recipient rate ranged from 0 to 46 per cent. More drug was given per patient in larger homes (r = .18, p less than .05). Typically, one physician (the "dominant" physician) provided care for the majority of a nursing home's patients. The proportion of a home's patients seen by the dominant physician was correlated with the chronic recipient rate (r = .17, p less than .05). These findings provide epidemiologic evidence suggesting misuse of antipsychotic drugs in nursing homes. They illustrate the need for investigations of techniques for patient management in nursing homes which rely less upon psychtropic drugs.




This article has been cited by other articles:


Home page
 Arch Intern MedHome page
P. A. Rochon, T. A. Stukel, S. E. Bronskill, T. Gomes, K. Sykora, W. P. Wodchis, M. Hillmer, A. Kopp, J. H. Gurwitz, and G. M. Anderson
Variation in Nursing Home Antipsychotic Prescribing Rates
Arch Intern Med, April 9, 2007; 167(7): 676 - 683.
[Abstract] [Full Text] [PDF]

Home page
 Med Care Res RevHome page
D. C. Grabowski and N. G. Castle
Nursing Homes with Persistent High and Low Quality
Med Care Res Rev, March 1, 2004; 61(1): 89 - 115.
[Abstract] [PDF]

Home page
 GerontologistHome page
X. Zhang and D. C. Grabowski
Nursing Home Staffing and Quality Under the Nursing Home Reform Act
Gerontologist, February 1, 2004; 44(1): 13 - 23.
[Abstract] [Full Text] [PDF]

Home page
 GerontologistHome page
N. G. Castle
Providing Outcomes Information to Nursing Homes: Can It Improve Quality of Care?
Gerontologist, August 1, 2003; 43(4): 483 - 492.
[Abstract] [Full Text] [PDF]

Home page
 Psychiatr. Serv.Home page
J. M. Ryan, S. W. Kidder, L. A. Daiello, and P. N. Tariot
Mental Health Services in Nursing Homes: Psychopharmacologic Interventions in Nursing Homes: What Do We Know and Where Should We Go?
Psychiatr Serv, November 1, 2002; 53(11): 1407 - 1413.
[Abstract] [Full Text] [PDF]

Home page
 J Geriatr Psychiatry NeurolHome page
R. A. Maxwell, R. A. Sweet, B. H. Mulsant, J. Rosen, M. A. Kirshner, K. B. Kastango, and B. G. Pollock
Risperidone and 9-Hydroxyrisperidone Concentrations Are Not Dependent on Age or Creatinine Clearance among Elderly Subjects
J Geriatr Psychiatry Neurol, June 1, 2002; 15(2): 77 - 81.
[Abstract] [PDF]

Home page
 JAMAHome page
C. Zhan, J. Sangl, A. S. Bierman, M. R. Miller, B. Friedman, S. W. Wickizer, and G. S. Meyer
Potentially Inappropriate Medication Use in the Community-Dwelling Elderly: Findings From the 1996 Medical Expenditure Panel Survey
JAMA, December 12, 2001; 286(22): 2823 - 2829.
[Abstract] [Full Text] [PDF]

Home page
 GerontologistHome page
N. G. Castle
Administrator Turnover and Quality of Care in Nursing Homes
Gerontologist, December 1, 2001; 41(6): 757 - 767.
[Abstract] [Full Text] [PDF]

Home page
 Psychiatr. Serv.Home page
B. L. Svarstad, J. K. Mount, and W. Bigelow
Variations in the Treatment Culture of Nursing Homes and Responses to Regulations to Reduce Drug Use
Psychiatr Serv, May 1, 2001; 52(5): 666 - 672.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
I. C. Sumaya, B. M. Rienzi, J. F. Deegan II, and D. E. Moss
Bright Light Treatment Decreases Depression in Institutionalized Older Adults: A Placebo-Controlled Crossover Study
J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2001; 56(6): M356 - M360.
[Abstract] [Full Text] [PDF]

Home page
 GerontologistHome page
N. G. Castle
Innovation in Nursing Homes: Which Facilities Are the Early Adopters?
Gerontologist, April 1, 2001; 41(2): 161 - 172.
[Abstract] [Full Text]

Home page
 BMJHome page
C. M Hughes, K. L Lapane, V. Mor, A Turrell, and C M Castleden
Impact of legislation on nursing home care in the United States: lessons for the United Kingdom • Commentary: A new script for nursing home care in the United Kingdom?
BMJ, October 16, 1999; 319(7216): 1060 - 1063.
[Full Text]

Home page
 Research on AgingHome page
D. A. McKenzie, J. P. Mullooly, B. H. McFarland, J. A. Semradek, and L. E. McCamant
Changes in Antipsychotic Drug Use Following Shifts in Policy: A Multilevel Analysis
Research on Aging, March 1, 1999; 21(2): 304 - 337.
[Abstract] [PDF]

Home page
 J Geriatr Psychiatry NeurolHome page
D.P. Devanand and S. R. Levy
Neuroleptic Treatment of Agitation and Psychosis in Dementia
J Geriatr Psychiatry Neurol, October 1, 1995; 8(1): S18 - S27.
[Abstract] [PDF]

Home page
 AM J ALZHEIMERS DIS OTHER DEMENHome page
M. F. Weiner and K. F. Gray
Balancing psychosocial and psychopharmacologic measures in Alzheimer's disease
American Journal of Alzheimer's Disease and Other Dementias, July 1, 1994; 9(4): 6 - 12.
[Abstract] [PDF]

Home page
 Clin RehabilHome page
A. Adunsky and M. Hershkowitz
The role of psychotropic drugs in the elderly with hip fractures
Clinical Rehabilitation, May 1, 1993; 7(2): 135 - 138.
[Abstract] [PDF]

Home page
 J Aging HealthHome page
D. L. Spore, A. L. Horgas, M. A. Smyer, and L. N. Marks
The Relationship of Antipsychotic Drug Use, Behavior, and Diagnoses among Nursing Home Residents
J Aging Health, November 1, 1992; 4(4): 514 - 535.
[Abstract] [PDF]

Home page
 Journal of Applied GerontologyHome page
D. Fitz and A. Mallya
Discontinuation of a Psychogeriatric Program for Nursing Home Residents: Psychotropic Medication Changes and Behavioral Reactions
Journal of Applied Gerontology, March 1, 1992; 11(1): 50 - 63.
[Abstract] [PDF]

Home page
 J Aging HealthHome page
G. Arling, B. J. Ryther, T. Collins, and D. Zimmerman
Mental Illness and Psychotropic Medication Use in the Nursing Home
J Aging Health, November 1, 1991; 3(4): 455 - 472.
[Abstract] [PDF]

Home page
 Journal of Applied GerontologyHome page
D. Fitz and A. Mallya
Behavioral Reactions to Psychotropic Medication Changes for Nursing Home Residents Receiving Psychogeriatric Programming
Journal of Applied Gerontology, June 1, 1990; 9(2): 194 - 210.
[Abstract] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
D. S. Sherman
Psychoactive Drug Misuse in Long-Term Care: Some Contributing Factors
Journal of Pharmacy Practice, December 1, 1988; 1(3): 189 - 194.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by the American Public Health Association